VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0936423
Sex: F
Age:
State: FL

Vax Date: 01/04/2021
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: to get Botox injection for her Dystonia; got her 1st dose of Covid vaccine last 04Jan and was scheduled to have her 2nd dose on 22Jan; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer(patient) reported that a 62-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient got her 1st dose of Covid vaccine last 04Jan2021 and was scheduled to have her 2nd dose on 22Jan2021, but she had an appointment 2 days prior this to get botulinum toxin type a (BOTOX) injection for her Dystonia. The patient wanted to know if it's ok for her to get 2nd dose of Covid vaccine after getting botulinum toxin type A. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0936424
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: having swelling at the injection site to her arm 10 days after the injection of the vaccine; This is a spontaneous report from a contactable physician. A 7-decade-old (reported as in her 60's) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. The reporter asked if it was normal for a patient to have delayed swelling at injection site on the arm after getting the vaccine. Reporter mentioned that she is a physician whose patient started having swelling at the injection site to her arm 10 days after the injection of the vaccine. Reporter asked should the patient receive the second dose of the vaccine. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936426
Sex: M
Age:
State: GA

Vax Date: 12/23/2020
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; Headaches; nausea; joint pain/pain in right wrist; numbness in left hand; feeling as if the room is moving sideways; pain in right wrist and finger; chest pain; This is a spontaneous report from a contactable Other healthcare professional (HCP) reporting for himself. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 23Dec2020 and ever since the patient had symptoms including chills, headaches, nausea, joint pain, numbness in left hand, pain in right wrist and finger, chest pain and then feeling as if the room is moving sideways from an unknown date. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936427
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Head is pounding (migraine); Jaw hurting; Neck is stiff; Can't sleep (haven't slept); This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 05Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. In Jan2021, the patient's head was pounding (migraine); jaw was hurting; neck was stiff; and she could not sleep (have not slept). The outcome of the events, 'head was pounding', 'jaw was hurting', 'neck was stiff' and 'could not sleep', was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936428
Sex: F
Age:
State: AZ

Vax Date:
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: minor fever; Result Unstructured Data: Test Result:minor fever

Allergies:

Symptoms: Headache; Nausea; Minor fever; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. caller wanted to know it the adverse reactions that she is experiencing could be due to the administration of the vaccine. She received the vaccine a week ago and she started to present the following side effects yesterday (05Jan2021): headache, nausea and minor fever. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936430
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Night sweats; Extreme nausea; Chills; Fever; Itch; This is a spontaneous report from a contactable Nurse (patient) reported for self. A female patient of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Nurse was asking for recommendations if she could get the 2nd dose of the vaccine after having adverse reactions on the 1st dose - experienced night sweats, extreme nausea, chills, fever, and itch. Nurse was also asking what are the signs of severe allergic reactions. The outcome of the events was not reported. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936432
Sex: F
Age:
State: KS

Vax Date: 12/01/2020
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: HR; Result Unstructured Data: Test Result:increased

Allergies:

Symptoms: SOB; feeling "panic-y"; increased HR; left lip numbness; pain down spine and neck; pain down spine and neck; weakness; head really heavy; This is a spontaneous report from a contactable pharmacist. A 50-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, lot no. and expiry date were unknown), via an unspecified route of administration in Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was given first round or shots 2-3 weeks ago. On unspecified date, the patient experienced SOB, feeling "panic-y", increased HR, left lip numbness (all of which resolved after a few hours). Then 4 days later she reported pain down spine and neck, weakness, head felt really heavy and hard to hold up which lasted several days to a week. The pharmacist was asking for extended stability of thawed vials in the refrigerator: at least 1 additional day would be helpful. The events resolved on unspecified date. Information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0936433
Sex: F
Age:
State: MI

Vax Date: 01/03/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Feeling dizzy; head hurt; fatigued; This is a spontaneous report from a contactable other health care professional (patient). A 35-year-old non-pregnant female patient received bnt162b2 (BNT162B2, lot no. and expiry date was unknown), via an unspecified route of administration in left arm on 03Jan2021 14:00 at single dose for Covid-19 immunization. The patient medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced feeling dizzy and her head hurt very bad and so fatigued on 05Jan2021. Since the vaccination, the patient has not been tested for COVID-19. There was no treatment received for the events. The outcome of the events was not recovered. The events were assessed as non-serious. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 0936434
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flu like symptoms like headache, chills, body aches; Flu like symptoms like headache, chills, body aches; Flu like symptoms like headache, chills, body aches; Flu like symptoms like headache, chills, body aches; This is a spontaneous report from a non-contactable Other-HCP. This Other-HCP reported for a 43-year-old female patient that received second dose of bnt162b2 (BNT162B2, Pfizer COVID-19, Batch/lot number: EL0142), via Intramuscular on 05Ja2021 02:00 PM at single dose on Left arm for covid-19 immunisation. She is not pregnant at the time of vaccination. Medical history included Known Allergies to medications, food, or other products: Sulfas and first dose of bnt162b2 (COVID 19) for covid-19 immunisation. Concomitant medications were none. Facility type vaccine was Hospital. No other vaccine in four weeks. No other medications in two weeks. The patient experienced Flu like symptoms like headache, chills, body aches from 05Jan202108:00 PM. No covid prior vaccination. No covid tested post vaccination. The event was assessed non-serious. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0936436
Sex: F
Age:
State: MN

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: aches; Chills; Headache; tight muscles; Hot flashes; Next 2 days: soreness in left arm; This is a spontaneous report from a contactable Other HCP (patient). This 30-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EK5730) intramuscular at left arm on 03Jan2021 at 10:30 AM at single dose for COVID-19 immunisation. Medical history was unknown. Concomitant medications included cyclobenzaprine, levothyroxine and drospirenone/ethinylestradiol (NIKKI). The patient experienced aches and chills, headache and tight muscles on 03Jan2021 at 13:00. Then the patient had hot flashes and soreness in left arm from 03Jan2021 next 2 days. No treatment was received. The patient had no allergies to medications, food, or other products. The patient was no pregnant. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination, no covid tested post vaccination. Outcome of all events was recovered.

Other Meds: ; ; NIKKI

Current Illness:

ID: 0936437
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash and itching on arms and legs; Rash and itching on arms and legs; This is a spontaneous report from a non-contactable pharmacist. A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK5730), intramuscular, on 22Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The most recent COVID-19 vaccine was administered in a hospital. From 23Dec2020 to 27Dec2020, the patient experienced rash and itching on arms and legs. The patient took diphenhydramine hydrochloride (BENADRYL) to improve symptoms. The events were considered non-serious. The patient recovered from the events on 27Dec2020. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0936439
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: tested; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: she tested positive 5 days after taking the first COVID19 Vaccine dose; she tested positive 5 days after taking the first COVID19 Vaccine dose; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient tested positive 5 days after taking the first COVID-19 vaccine dose. Outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936440
Sex: F
Age:
State: OH

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: Fever of 103; Result Unstructured Data: Test Result:103

Allergies:

Symptoms: chills/rigors; Fever of 103; muscle pain; headache; This is a spontaneous report from a contactable nurse. A 47-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration at the left arm on 05Jan2021 08:30 at a single for COVID-19 immunization at a hospital. Medical history included hypothyroidism. Patient has no allergies to medications, food, or other products. Concomitant medications included levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO), and calcitriol. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via unspecified route of administration at the left arm on 15Dec2020 16:00 at a single dose for COVID-19 immunization. The patient experienced fever of 103, rigors, muscle pain, headache, and chills, lasted 12 hours on 6Jan2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any treatment for the events. The patient was recovering from the events.

Other Meds: SYNTHROID; LEXAPRO;

Current Illness:

ID: 0936442
Sex: M
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I have my armpit swollen; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number EJ1484), via an unspecified route of administration on 04Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported. It was mentioned that the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EH9899) as COVID-19 immunization and had no secondary effects. It was mentioned that with the second dose that was on 04Jan2021, he had armpit swollen (noted in Jan2021) but it doesn't hurt or anything but its swollen. Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0936443
Sex: M
Age:
State: FL

Vax Date: 12/17/2020
Onset Date: 12/01/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash/ super itchy at night; maculopapular rash; he can not sleep great; This contactable physician reported similar events for two patients. This is the first of two reports. This physician which was a 49-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EH9899), via an unspecified route of administration on the right deltoid 17Dec2020 at SINGLE DOSE for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient stated that he received the first dose of the COVID vaccine and he had a pretty bad rash that started 3 days after (noted on 20Dec2020). The rash has since improved since it started but it took forever to improve and mentioned that he was super itchy at night. He also used to be itchy in the day, but now it was just at nigh which was driving him insane. The physician also mentioned that it was a raised maculopapular rash. It started on his neck on the left side as well and increased of both elbows and behind his knees (it was diffuse). He mentioned that he was able to carry on during the day, but he cannot sleep great. He mentioned that it reminded him of poison ivy - the thought of it happening again makes him want to cringe especially with all the terrible stuff he has seen he was scared that his skin will slough off or its going to kill him or something. But overall, he was more concerned about the itching. The physician took over the counter antihistamines and hydrocortisone cream. He did take one dose of expired liquid prednisone (from 5 years ago that his daughter who had for an ear infection). He downed a sip of prednisone and it prevented his itchiness for a day and now was thinking of getting on steroids. The physician also stated that there was one guy he worked with had something similar (AER 2021010285). He received the same lot number and has been itching like crazy. They have both been trying to figure out what to do. It was clear as mud. Then, last week (Jan2021) they saw each other, and they were both having the same issue and suffering separately. They had no exposure to anything similar besides the vaccine. The physician stated that he was about due for 2nd shot. He has been researching and trying to figure out what to do, if he should get the second dose or not. He reported this to VAERs and talked to CDC, but nobody has any recommendations or information. He also tried to look up trial data to see if anyone had reported a similar rash, and he did not find anything. He was calling to see if he should get the second dose, and if Pfizer has any information on this rash being reported. Outcome of pruritic rash was not recovered; recovering from maculopapular rash and unknown for the remaining event. As per causality: He was unsure. It was most likely from the vaccine as he has done nothing differently.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021010285 same reporter/drug, similar events, different patient;US-PFIZER INC-2021010285 same reporter/drug, similar events, different patient

Other Meds:

Current Illness:

ID: 0936444
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tongue was thick; numbness on face/started on the left side but now her whole face was numb; whole face/swelling; dizzy; felt like she was floating/felt like she could get a nosebleed; teeth hurt; hands were swelling and it's hard to write; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Jan2021 at a single dose as vaccine. Medical history and concomitant medications were not reported. It was reported that received vaccine today, 06Jan2021, at 11:00. The patient's tongue was thick, she had numbness on face that started on the left side but now her whole face was numb and swelling. She was dizzy and felt like she was floating, her teeth hurt, her hands were swelling and it's hard to write, and felt like she could get a nosebleed. She took two Benadryl at 12:06 that expired in 2013 and then 2 more Benadryl at 1:08 that do not expire until 2022. She inquired if should she seek medical attention or ride this out and if should she follow through with her second dose of the vaccine. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936446
Sex: M
Age:
State: NY

Vax Date: 12/19/2020
Onset Date: 12/31/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20201231; Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020; received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020; This is a spontaneous report from a contactable other HCP (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 19Dec2020 at the first single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020. The outcome of events was unknown. Information about Lot/Batch has been requested.; Sender's Comments: A causal association between reported event and BNT162B2 cannot be excluded.

Other Meds:

Current Illness:

ID: 0936447
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; sore arm; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on 05Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history included mononucleosis. The patient's concomitant medications were not reported. In Jan2021, the patient experienced headache and sore arm with unknown outcomes. The patient was asking if she can resume her treatment with amoxicillin as she was supposed to be taking antibiotics. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936448
Sex: F
Age:
State:

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After vaccine administration, pt experienced severe diarrhea with incontinence.; After vaccine administration, pt experienced severe diarrhea with incontinence.; This is a spontaneous report from a non-contactable pharmacist. A 78-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EK5730, intramuscular from 16Dec2020 to 16Dec2020 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. After vaccine administration on 16Dec2020, The patient experienced severe diarrhea with incontinence. The outcome of the events was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0936450
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:103 Fahrenheit

Allergies:

Symptoms: fever, at 103?F; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (reported as Age: 28, Unit: Unknown) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 05Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and patient's concomitant medications were not reported. The patient received the vaccine on 05Jan2021 and experienced fever at 103 F on 05Jan2021. She then asked if she should be alarmed or was it a reported side effect of the vaccine. The outcome of the event was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936451
Sex: F
Age:
State: TX

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle aches on legs; sore arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date: unknown), via an unspecified route of administration on 05Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received the COVID-19 vaccine yesterday (05Jan2021). She had a sore arm and muscle aches on legs that has been expectedly worse on an unspecified date in Jan2021. Outcome of the events was unknown. Patient was asking if it was okay to take TYLENOL for her adverse events. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936452
Sex: F
Age:
State: LA

Vax Date: 12/21/2020
Onset Date: 12/29/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20201229; Test Name: covid19; Test Result: Positive

Allergies:

Symptoms: tested positive for covid19; tested positive for covid19; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received vaccine 1st dose on 21Dec2020 and on 29Dec2020 she tested positive for covid19. She is coming up on 2nd dose on Friday (will be out of quarantine on the same day), she asked if she should get the vaccine. Her primary care physician advised her not to receive, within 30 days because there had been reports of people having reactions (ie: high fevers) to the vaccine. If she has a high fever she can't go to school. She asked if waiting 90 days make the vaccine not as effective and if she need to restart the series. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Test positive for covid19 found 7 day following the vaccination, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag

Other Meds:

Current Illness:

ID: 0936454
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Negative

Allergies:

Symptoms: moderate, and intermittent nausea; lack of appetite; fatigue; malaise; sometimes chills; This is a spontaneous report from a contactable nurse (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. A couple of hours after she received the Pfizer-BioNTech Covid-19 Vaccine last 21Dec2020, she started to experience moderate, and intermittent nausea, lack of appetite, fatigue, malaise, and sometimes chills; all on 21Dec2020. She said that the worse of all side effects she's experiencing was nausea. HCP also said that she was still experiencing the side effects until now. She also mentioned that she got tested for Covid, and results came back negative. However, she said that she will get tested again just to make sure she did not have the virus. The events were reported as non-serious. The outcome of events was not resolved. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0936455
Sex: F
Age:
State: NJ

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: unknown cause of diarrhea 2 days after; This is a spontaneous report from a contactable other HCP reported for self. This 47-year-old female patient (Not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 29Dec2020 16:30 PM on Left arm at single dose (Lot # Ej1685) for covid-19 immunisation. Medical history was not provided. Concomitant medications included escitalopram. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Past drug history included Known allergies: may be Dilaudid. She had unknown cause of diarrhea 2 days after on 31Dec2020. Last only one day. No other symptoms. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. No treatments were received. Outcome of the event was recovered on 01Jan2021.

Other Meds:

Current Illness:

ID: 0936456
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:Abmormality; Test Name: blood pressure; Result Unstructured Data: Test Result:hypotension; Comments: rapid progression

Allergies:

Symptoms: collapse/rapid progression of symptoms; hypotension/rapid progression of symptoms; respiratory distress with stridor; respiratory distress with stridor; dizziness/rapid progression of symptoms; not limited to abdominal pain/rapid progression of symptoms; blood pressure abnormality/rapid progression of symptoms; chest pain/rapid progression of symptoms; drooling/rapid progression of symptoms; increased swelling/rapid progression of symptoms; wheezing; dyspnea and increased work of breathing; skin changes; tongue swelling and vomiting; tongue swelling and vomiting; This is a spontaneous report from a non-contactable other health professional. A 35-year-old female patient (Age at vaccination: 35) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. During her 15 minute waiting period after the injection, the patient began to experience dizziness. Monitored patient for severe reaction symptoms, including but not limited to abdominal pain, blood pressure abnormality, chest pain, collapse, drooling, hypotension, increased swelling, rapid progression of symptoms, respiratory distress with stridor, wheezing, dyspnea and increased work of breathing, skin changes, tongue swelling and vomiting. Treatment included: no therapy. The outcome of the events was unknown. No follow up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the collapse, hypotension, respiratory distress and other reported events due to temporal relationship. There is very limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including BP measurements, chest x-ray, EKG and chemistry panel, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0936457
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Escherichia Coli infection; This is a spontaneous report from a non-contactable consumer (daughter) from a Pfizer sponsored program Pfizer First Connect. A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter's mother has Escherichia Coli infection and is taking Nitrofurantoin antibiotic (Macrodantin). Asked if it is safe to take the second dose of the vaccine while on antibiotic. Caller asking if we could update info regarding antibiotic as even her doctor does not have info on this. Saying that even her doctor is unsure as Pfizer should know information regarding this more than her doctor. Treatment for event was Nitrofurantoin antibiotic (Macrodantin). Outcome of event was unknown. No follow up attempts are possible; Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0936458
Sex: F
Age:
State: CA

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: fever; Result Unstructured Data: Test Result:102

Allergies:

Symptoms: Fever up to 102; body aches; hip and back joint pain; chills; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (lot number: EH9899) on 18Dec2020 17:00 (first dose) then (lot number: EC1284) on 05Jan2021 07:45 (second dose); both intramuscular on the left arm at a single dose for COVID-19 immunization. The patient's medical history included anxiety and depression. The patient was not pregnant at the time of vaccination. Concomitant medication included citalopram and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took amoxicillin and experienced allergies to amoxicillin. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 05Jan2021 17:30, the patient experienced fever up to 102, body aches, hip and back joint pain, chills, and fatigue. Outcome of the events was recovering. The events were considered non-serious by the reporter.

Other Meds:

Current Illness:

ID: 0936459
Sex: F
Age:
State: NJ

Vax Date: 12/22/2020
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Pending

Allergies:

Symptoms: Have a cold and headache; headache; loss smell/ taste; loss smell/ taste; This is a spontaneous report from a contactable healthcare professional (patient). A 46-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Es1685, expiry date not reported), via an unspecified route of administration on 22Dec2020 at 09:30 AM at single dose for Covid-19 immunization. There were no medical history and no concomitant medications, no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines with 4 weeks prior to COVID vaccine nor any other medications within 2 weeks of vaccination. On 01Jan2021, the patient has a cold and headache, she was sent for Covid test 1/5 loss smell/ taste 1/3. The patient did not receive treatment for the events. The patient underwent lab test on 06Jan2021 which included nasal swab: pending result. Outcome of the events was recovered. The reporter assessed the events as non-serious. Information on Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0936460
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; This is a spontaneous report from a contactable healthcare professional (patient). A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 06Jan2021 (13:15) at a single dose, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included abnormal Factor V; and kiwi allergy. Concomitant medication included ibuprofen (ADVIL). The patient previously took Ambroxol, and had drug allergy. The patient was not diagnosed with COVID-19 prior to vaccination, and has not been tested since the vaccination. On 06Jan2021 (16:00), the patient had sore arm. The patient did not receive any treatment for the event. The outcome of the event, sore arm, was unknown. Information on batch/lot number was requested.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 0936461
Sex: F
Age:
State: OK

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: too sick; Fever; muscle aches; headache; body aches; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; unknown lot number and expiration date), via an unspecified route of administration left arm on 04Jan2021 19:30 (07:30 PM) at a single dose for covid-19 immunization. The patient medical history was not reported. The patient has no allergies to medications, food, or other products. Concomitant medication included escitalopram oxalate (LEXAPRO) and ergocalciferol (VIT D). The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The most recent COVID-19 vaccine was administered in a hospital. The patient experienced fever, muscle aches, headache and body aches on 05Jan2021 09:00 PM (21:00). The patient was too sick to get out of bed to find lot details. The patient did not received treatment for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the event sickness was unknown while the outcome of the other events was recovering. Information on the lot/batch number has been requested.

Other Meds: Lexapro; Vit D

Current Illness:

ID: 0936462
Sex: M
Age:
State: AZ

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: COVID test; Result Unstructured Data: Test Result:has no positive COVID test

Allergies:

Symptoms: he is also not drinking; pain at injection site; coughing/cough; chills; not wanting to eat and fatigue; not wanting to eat and fatigue; feeling of being drowsy, like he is going to get a cold; This is a spontaneous report from a contactable consumer (patient himself). A 53-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration (arm left), on 04Jan2021 at 14:15, at a single dose, for COVID-19 immunization. Patient has no relevant medical history. Concomitant medications included metformin, empagliflozin (JARDIANCE), lisinopril, and pravastatin. Historical vaccine included shingles; and flu shot for flu vaccination both administered in Jan2020. Patient is Behavioral Health Technician. Patient received the first dose of vaccine on 04Jan2021 (Monday) at 14:15 and went through cough, chills, not eating, fatigue. Today (Wednesday) he is better; he asked if he can take ibuprofen after having the vaccine. He also asks how long do these symptoms typically last. All the symptoms he mentioned started around 8:00 p.m. the same day, it was that feeling of being drowsy, like he is going to get a cold. He also had excruciating pain on the arm that got the vaccine, it was pain at the injection site. He added that he was also not drinking, he knows he should drink fluids. His second dose is on 26Jan2021 at 8:45PM. He has no positive COVID test before the vaccine. He did not have antibody test before the vaccine. He has had no issues with vaccines in the past. Outcome of the events not wanting to eat and fatigue was not recovered, for event "he is also not drinking" was unknown, while for other events was recovering. Information about lot/batch number has been requested.

Other Meds: ; JARDIANCE; ;

Current Illness:

ID: 0936464
Sex: F
Age:
State: NY

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: temperature; Result Unstructured Data: Test Result:100.7; Comments: Her temperature reached 100.7. This happened on 05Jan2021.

Allergies:

Symptoms: swelling and pain on the arm that was injected; swelling and pain on the arm that was injected; Lethargic; Fever/temperature reached 100.7; fatigued/ tired; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect from a contactable Female consumer (Patient). A female patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0142, Expiry Date: 20Mar2021), via an unspecified route of administration on 04Jan2021 at single dose for COVID-19 immunization. Medical history included torn rotator cuffs, ongoing chronic obstructive pulmonary disease (COPD), immunocompromised, shoulder pain that she was getting the cortisone shot for was prior to the COVID shot. She also reported that she took prednisone regularly. The patient's concomitant medications were not reported. The patient got the first dose of the vaccine on 04Jan2021. She was scheduled to have cortisone injections to both of her shoulders for torn rotator cuffs on 13Jan2020 and then scheduled to get the second dose of the covid vaccine on 24Jan2020. The caller confirmed that the shoulder pain that she was getting the cortisone shot for was prior to the COVID shot and she had been getting them for some time. She mentioned she had a reaction to the first shot, she had swelling and pain on the arm that was injected. Also, she had a fever and felt lethargic that night but the next day she felt fine. The next day she actually could hardly get out of bed and felt fatigued and tired. Her temperature reached 100.7. This happened on 05Jan2021. At time of the report, she felt fine and the events resolved. She really just wanted to know if the shots would interfere with each other. Events reported as non-serious. The outcome of event fatigued/ tired was unknown, of the other events was recovered on 06Jan2021.

Other Meds:

Current Illness: COPD

ID: 0936465
Sex: F
Age:
State: LA

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; head ache; severe joint pain; nausea; congestion; severe weakness; This is a spontaneous report from a contactable nurse (patient herself). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date unknown) via an unspecified route of administration on 05Jan2021 07:45AM at a single dose for COVID-19 immunization. The patient's medical history included hypothyroid and ADD (Attention Deficit Hyperactivity Disorder), both from an unknown date and unknown if ongoing. The patient had known allergies to PCN. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Concomitant medications included unspecified/ other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Jan2021 09:00 AM, the patient experienced fever, chills head ache, severe joint pain, nausea, congestion, and severe weakness. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received treatment for the events. Outcome of the events was unknown. The report was assessed as non-serious; the events did not result in death, were not life threatening, did not caused/prolonged hospitalization, were not disabling/ incapacitating, and did not caused any congenital anomaly/birth defect. Information about lot/batch number is requested.

Other Meds:

Current Illness:

ID: 0936466
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Fatigue; Muscle aches; Headache; Interval between the two COVID-19 vaccine doses is 18 days; This is a spontaneous report from a contactable nurse (patient). An adult female (non-pregnant) patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration in left arm, on 05Jan2021 at 7:30, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (Lot Number: EJ1685) on 18Dec2020 for COVID-19 immunization (right arm). The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccines. Prior to vaccination, the patient was not diagnosed with COVID-19. The most recent COVID-19 vaccine was administered in a hospital. The interval between the two COVID-19 vaccine doses is 18 days (18Dec2020 to 05Jan2021). On 05Jan2021 at 3 PM, the patient experienced fever, fatigue, muscle aches, and headache. The events were considered non-serious. No treatment was received for the adverse events. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events in Jan2021.

Other Meds:

Current Illness:

ID: 0936467
Sex: M
Age:
State: WV

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: temperature; Result Unstructured Data: Test Result:99.4; Comments: 02:30; Test Date: 20201226; Test Name: PCR test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: loss of smell and taste; loss of smell and taste; low grade fever; Flu-like aching; headache; coughs; soreness of the arm; This is a spontaneous report from a contactable consumer (patient work in detention center). A 45-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL1284, Expire Date: 30Apr2021), via an unspecified route of administration on 05Jan2021 07:45 in the right arm at single dose for covid-19 immunisation. Medical history included covid-19 from 26Dec2020 was recovering. The patient's concomitant medications were not reported. The patient experienced soreness of the arm on 05Jan2021 with outcome of recovering, loss of smell and taste on 06Jan2021 04:00 with outcome of not recovered, headache on 06Jan2021 with outcome of recovered, coughs on 06Jan2021 with outcome of not recovered, low grade fever on 06Jan2021 02:30 with outcome of unknown, flu-like aching on 06Jan2021 01:00 with outcome of recovering. The detail clinical course was provided as consumer calling regarding the COVID 19 vaccine. He received first dose of the Pfizer COVID 19 vaccine on 05Jan2021 07:45am in the right arm. He noticed by the afternoon his arm was sore. He worked overnight so at 01:00AM 06Jan2021 he noticed achy, like flu ache in his muscles. He took his temperature and it was 99.4 around 02:30 in the morning. Then at 04:00am he noticed he couldn't smell or taste anything. He went home and fell asleep. When he woke up he had a headache and coughing. He took Dayquil which helped with the coughing and then the headache went away. He has had the coughing all through the COVID infection. The patient underwent lab tests and procedures which included body temperature: 99.4 on 06Jan2021 02:30, COVID 19 test PCR positive 26Dec2020. The events were reported as non-serious. Mentioned he was told if you already had COVID the side effects of the vaccine may be worse. He was planning to receive the second dose 26Jan2021.

Other Meds:

Current Illness:

ID: 0936468
Sex: F
Age:
State: UT

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild arthritis joint pain in my hands, and feet/The pain and inflammation has significantly increased; Mild arthritis joint pain in my hands, and feet/The pain and inflammation has significantly increased; pain and inflammation has significantly increased; feels very sharp especially in my hands in my back near my scapula, and my knee joints; My muscles also feel tight in these areas; The pain and discomfort are significantly greater than normal; This is a spontaneous report from a contactable other hcp. This 47-year-old female other HCP (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular on 30Dec2020 09:00 at single dose on right arm for COVID-19 immunisation. The patient was mostly healthy, no chronic health conditions. No known allergies. Her family had a lot of auto immune disease history. Concomitant medication included paracetamol (TYLENOL), ibuprofen. The patient had mild arthritis joint pain in her hands, and feet that were usually resolved with OTC pain medications. The pain and inflammation has significantly increased since the COVID-19 vaccine injection and felt very sharp especially in her hands, in her back near mhery scapula, and her knee joints. Her muscles also feel tight in these areas. The pain and discomfort are significantly greater than normal. Symptoms were the worst 2-5 days Post injection and have not resolved. All of the events were on 31Dec2020 09:00 and no treatment was received, all considered as non-serious. No COVID tested post vaccination. The outcome of the events was not recovered. Information on the Lot/Batch number has been requested.

Other Meds: TYLENOL;

Current Illness:

ID: 0936469
Sex: F
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash on her belly and torso area; Left arm soreness; This is a spontaneous report from a contactable nurse (patient). A 54-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EJ1686) via an unspecified route of administration in left arm on 28Dec2020 11:15 at single dose for COVID-19 immunisation. There was no medical history. The patient only takes vitamins; has no underlying conditions. There were no concomitant medications. 20 years ago, the patient had flu like symptoms after the Flu vaccine. Last vaccine was a Tetanus shot 8-10 years ago. The patient received COVID-19 vaccine through hospital on 28Dec2020 at 11:15 in left arm. Left arm soreness noticed in morning on 29Dec2020. Forty-eight hours later (15:00 on 30Dec2020) had a rash on her belly and torso area. Rash was no where else. Is due to get second dose on 18Jan2021. She wants to know if it is OK to receive second dose. Clarified she is referring to the Pfizer COVID-19 Vaccine. Clarified soreness was noticed only in the injection arm. Was noticed in morning. Noticed rash at 15:00 on 30Dec2020. She took benedryl x 3 doses and the rash and symptoms were gone on 31Dec2020. Event outcome of rash on her belly and torso area was recovered on 31Dec2020, while for others was unknown.

Other Meds:

Current Illness:

ID: 0936470
Sex: F
Age:
State:

Vax Date: 12/20/2020
Onset Date: 12/22/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: tested positive for Covid; Test Result: Positive

Allergies:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient tested positive for Covid on 22Dec2020. She wanted to know if there is any more information on receiving the second dose after testing positive. The outcome of the event was unknown. Information on the Lot/batch number has been requested.; Sender's Comments: Based on the mechanism of action of BNT162B2 vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine was given (in this case 2 days). However, a causal relationship between event "tested positive with Covid " (coded to Drug ineffective / SARS-CoV-2 test positive) and BNT162B2 vaccine cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0936471
Sex: F
Age:
State:

Vax Date: 12/17/2020
Onset Date:
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hives; This is a spontaneous report from a contactable nurse reported for herself. This female patient with unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 17Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient received her first dose of vaccine on 17Dec2020, and reported hives as a result. She's asking about efficacy of just 1 dose, and if she should get the 2nd dose. Also wanting to know duration of immunity. The outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0936472
Sex: M
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:elevated

Allergies:

Symptoms: felt hot; flush; light headed; heart rate elevated; fever; This is a spontaneous report from a contactable consumer (patient). This 37-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EH9899) via an unspecified route of administration at right arm on 06Jan2020 12:15 PM at single dose for COVID-19 immunisation. Medical history included known allergies to Penicillin and Hashimoto's thyroiditis. Concomitant medications included atorvastatin and clarithromycin (CLARITIN). The patient previous took Amoxicillin and Azithromycin, both experiencing allergies; the 1st dose of flu shot on 21Dec2020 at arm left. Within 5 minutes of injection, the patient felt hot, flush, light-headed and heart rate elevated from 06Jan2021 at 12:30 PM. The patient was under observation and the nurse laid him down in a room. The patient was monitored vitals with a doctor. Symptoms subsided and stopped by 30 minutes post injection. The patient felt normal and fine after fever. The patient did not have any symptoms himself. No treatment was received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of all events was recovered.

Other Meds: ; CLARITIN [CLARITHROMYCIN]

Current Illness:

ID: 0936474
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/25/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: she received the Pfizer-BioNTech Covid-19 Vaccine .She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas; she received the Pfizer-BioNTech Covid-19 Vaccine .She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas; after being exposed to someone infected with the virus; This is a spontaneous report from a contactable Physician (patient). A female patient of an unspecified age receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient she received the Pfizer-BioNTech Covid-19 Vaccine on 18Dec2020. She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas (25Dec2020). Now, she wanted to know if she can still take the 2nd dose. The outcome of the events was unknown. Information on the Lot/Batch number has been requested.; Sender's Comments: A causal association between reported event and BNT162B2 cannot be excluded.

Other Meds:

Current Illness:

ID: 0936475
Sex: F
Age:
State: CA

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: phlegm in throat; Headache; Dry cough; It just made her uncomfortable; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EL1284), intramuscular on the left arm on 04Jan2021 15:01 (she would say 15:01 because they told her to wait 20 minutes after receiving the vaccine and she left at 15:21) at SINGLE DOSE for COVID-19 immunization. The patient stated that she might be a little obese. There were no concomitant medications. When she got the vaccine on Monday (04Jan2021), she felt okay. The next day, it seemed like she had phlegm in her throat. She also had a horrible cough and headache. She don't know if it's the vaccine or what. It was mentioned that the phlegm in her throat was no longer horrible went away by the same day of 05Jan2021. The patient also stated that she took two acetaminophen (TYLENOL) for the headache and it went away last night (05Jan2021). However, she has the headache again by 06Jan2021. It was also mentioned that her dry cough that just won't go away, it's persisting. She can't cough, because people don't like that- they get uncomfortable. The patient mentioned that she didn't see any of these side effects on the paper she was given. It just made her uncomfortable, she didn't know what was going on with her body. Outcome of the events of productive cough and headache (initial occurrence) were recovered in 05Jan2021; recovering from dry cough; not recovered for headache (recurrence) while unknown for the remaining event.

Other Meds:

Current Illness:

ID: 0936476
Sex: M
Age:
State: NJ

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: Fever; Result Unstructured Data: Test Result:low grade fever

Allergies:

Symptoms: Mild injection site pain initially, next day increased injection site pain; Headache; Malaise; Low grade fever; This is a spontaneous report from a contactable pharmacist. This pharmacist (Patient) reported that the 29-year-old male patient received first dose of bnt162b2 (BNT162B2, Pfizer COVID-19, Batch/lot number: EL1284), via an unspecified route of administration on 04Jan2021 02:30 PM at single dose on Left arm for covid-19 immunisation. Medical history included covid prior vaccination. No Known Allergies to medications, food, or other products. Facility type vaccine was hospital. No other vaccine in four weeks. No other medications in two weeks. The patient experienced Mild injection site pain initially, next day increased injection site pain, malaise, low grade fever, and headache from 04Jan2021 03:00 PM. No covid tested post vaccination. The event was assessed non-serious. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. No treatment was received for the adverse event. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0936478
Sex: F
Age:
State: MT

Vax Date: 12/18/2020
Onset Date: 01/04/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: covid/nasal swab test; Test Result: Positive

Allergies:

Symptoms: tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer received from a Pfizer-sponsored program Pfizer First Connect. A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899, expiry date Mar2021, NDC 59267-1000-1), intramuscular in right arm on 18Dec2020 11:45 at a single dose as prevention. The vaccine was administered in the hospital. Medical history included ongoing cardiomyopathy diagnosed about 32 years ago and had pacemaker defibrillator Placed about 12 years ago. There were no concomitant medications. She was supposed to get the second dose of the Covid vaccine but she was positive for Covid. She found out she was positive for covid on Monday 04Jan2021 after she had a nasal swab test on 02Jan2020. The outcome of the event was unknown.

Other Meds:

Current Illness: Cardiac pacemaker insertion (Placed about 12 years ago.); Cardiomyopathy (Diagnosed about 32 years ago.)

ID: 0936479
Sex: F
Age:
State: OR

Vax Date: 01/03/2021
Onset Date: 01/03/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; headache; fever; body chills; wasn't able to sleep; pain throughout her arm/injection site was extremely sore; This is a spontaneous report from a contactable healthcare professional. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number ek9231/expiration date unknown), dose number 1, via an unspecified route of administration on 03Jan2021 14:15 at a single dose on the left arm for COVID-19 immunization. Medical history included migraines. Concomitant medications were not reported. The patient was fine the day she got the vaccine, but when it came to the night of 03Jan2021, she wasn't able to sleep due to the pain throughout her arm. On 04Jan2021 04:00, she woke up with a headache that was intense, fever, and body chills. The injection site was extremely sore to the point where she took some Tylenol and slept it off. On 05Jan2021, she felt a lot better, but still with mild body aches. The patient was not diagnosed with COVID-19 prior to vaccination. She was not tested for COVID-19 since the vaccination. The vaccine was received in a hospital. No other vaccines were given in four weeks. The outcome of the events was not recovered for body aches, and recovering for the other events.

Other Meds:

Current Illness:

ID: 0936481
Sex: F
Age:
State: WA

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe diarrhea for 3-4 hours starting 2 hours after vaccine; headache; Fatigue for several day; This is a spontaneous report from a contactable other HCP. A 43-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in left arm on 20Dec2020 17:30 at a single dose for covid-19 immunisation. The vaccine was administered in the hospital. Medical history included asthma. The patient was not diagnosed COVID-91 prior to vaccination. There were no concomitant medications. On 20Dec2020 21:00, the patient experienced severe diarrhea for 3-4 hours starting 2 hours after vaccine, fatigue for several days and headache. The outcome of the events was recovered on an unknown date. No treatment was required for the events. The patient was not tested for covid-19 post vaccination. Information about lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0936482
Sex: F
Age:
State: NV

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The swelling started on 31Dec2020 like a knot under the skin at the site of the injection; Soreness in her arm; Redness; This is a spontaneous report from a contactable consumer (patient herself). A 51-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration (left arm), on 29Dec2020 at 13:00 at a single dose, for COVID-19 immunization. Medical history included Modular Sponge Kidney stage one (being monitored; this predates her vaccination), Gastrooesophageal reflux disease (GERD), and high cholesterol. Family history included diabetes. Concomitant medications included dexlansoprazole (DEXILANT) from an unspecified date and ongoing for 10 years for GERD, ongoing estrogens conjugated, medroxyprogesterone acetate (PREMPRO) for hormone replacement therapy, pravastatin from an unspecified date and ongoing for 2 years and ezetimibe from an unspecified date and ongoing for six months both taken for high cholesterol. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in a drug store.This pharmacy tech received the vaccine on 29Dec2020 at 1300 in the left arm and then had some of the soreness, redness, swelling, and a large knot that grew to the size of a 50 cent piece. It went away and then it came back. She noticed the soreness in her arm and redness at the site on 30Dec2020. The swelling started on 31Dec2020 like a knot under the skin at the site of the injection which grew to the size of a 50-cent piece. The knot went away by the 02Jan2021. Then it started to come back yesterday 05Jan2021 with a knot; and today 06Jan2021 it is also red again and the size of a quarter. Patient is planning to have the second dose on 19Jan2021. She has not treated herself in any way other than rubbing the site. The events did not require emergency or physician visit. Outcome of the events was not recovered. Information on the batch/lot number has been requested.

Other Meds: DEXILANT; PREMPRO; ;

Current Illness:

ID: 0936484
Sex: F
Age:
State: NJ

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; fever; This is a spontaneous report from a contactable nurse. A 25-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 04Jan2021 14:00 in left arm at single dose for COVID-19 immunization. Medical history included Crohn's disease from an unknown date. The previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Dec2020 14:30 in right arm at single dose for COVID-19 immunization. The patient's concomitant medications were not reported. The patient experienced headache and fever on 05Jan2021 01:00. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovered in Jan2021. The patient was given over the counter medication as treatment for the events. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds:

Current Illness:

ID: 0936489
Sex: U
Age:
State: MN

Vax Date: 12/30/2020
Onset Date: 01/01/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizziness; Nausea; fatigue; hives; headache; This is a spontaneous report from a contactable Other HCP (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EJ1685) intramuscular in left arm on 30Dec2020 08:00 at single dose for COVID-19 immunization. Medical history included Crohn's Disease, rheumatoid arthritis. The patient was known allergic to IV contrast dye, sulfa, darvacet, demoral (coded as demerol). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included citalopram and clarithromycin (CLARITIN). The patient experienced Nausea, hives, dizziness, headache, and fatigue on 01Jan2021 12:00 PM. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Received Hydroxizine as treatment for the adverse event. Events outcome was recovering.

Other Meds: CLARITIN [CLARITHROMYCIN];

Current Illness:

ID: 0936491
Sex: F
Age:
State: AZ

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/12/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: SBP; Result Unstructured Data: Test Result:147; Comments: 09:30; Vital signs were taken SBP 147 HR 100s; Test Date: 20210105; Test Name: SBP; Result Unstructured Data: Test Result:117; Comments: 09:40: Second set of Vitals SBP 117 HR in the 80s; Test Date: 20210105; Test Name: HR; Result Unstructured Data: Test Result:100s; Comments: 09:30; Vital signs were taken SBP 147 HR 100s; Test Date: 20210105; Test Name: HR; Result Unstructured Data: Test Result:80s; Comments: 09:40: Second set of Vitals SBP 117 HR in the 80s

Allergies:

Symptoms: muscle joint pint in the fingers on left hand; Feeling shaky and cold; Feeling shaky and cold; HR 100s; SBP 147; left arm started to have tingling sensation. the sensation got worse as the minutes passed/tingling on right side of the face below eye; This is a spontaneous report from a contactable Nurse. A 39-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284), intramuscular (left arm, dose 1) on 05Jan2021 09:00 at single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. No other vaccines in four weeks. No other medications in two weeks. The patient previously took rocephine and experienced rash. On 09:03, patient received vaccine. On 09:07, left arm started to have tingling sensation. the sensation got worse as the minutes passed. On 0930; vital signs were taken (SBP 147, HR 100s). On 09:40, second set of Vitals (SBP 117, HR in the 80s). On 1028, tingling on right side of the face below eye. On 10:38, tingling on the face got better. Feeling shaky and cold. On 11:15, muscle joint pint in the fingers on left hand. On 13:30, most of the symptoms disappeared. Tingling on left arm still present mostly on in the tip of fingers and inner aspect of the forearm that comes and goes. Symptoms are not as bad as the first 50 minutes into the vaccine. Events occurred on 05Jan2021. No treatment was given. Since the vaccination, the patient has not been tested for COVID-19. Event outcome was recovering. The reporter considered the events as non-serious.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm